Welcome from the Chair
Olivier Rascol, MD, PhD
Professor of Clinical Pharmacology at Toulouse University Hospital, Toulouse, France
MDS-European Section Chair
I am pleased to look back on a highly successful year for the International Parkinson and Movement
Disorder Society European Section (MDS-ES). The accomplishments of our Section rely on the participation of its membership, which reached
an all-time high of over 1,600 members from 49 countries. The growing enthusiasm from members around Europe lead us to expand a number of programs this year that encourage scientific developments in our field and enhance the knowledge of Movement Disorders.
MDS-ES held 15 educational events in 2014, an increase from eight events in 2013, in addition to organizing collaborative education with the European Federation of Neurological Societies (EFNS) and the European Association of Nuclear Medicine (EANM). Educational programs have been held in Serbia, Hungary, Italy, Sweden, Spain, Portugal, Greece, Germany, Slovenia, Ukraine, Morocco, Russia, Udmurtia, Moldova and Bulgaria. I’m pleased to report that we reached an agreement with the newly formed European Academy of Neurology (EAN) which will enhance our ability to disseminate knowledge about Movement Disorders in Europe.
As the Section has grown, our ability to offer educational funding and other grant opportunities for our members have increased. Please see the side bar for further information about MDS-ES grant opportunities and I encourage you to take advantage of these opportunities.
I congratulate our 2015 Visiting Trainee grant recipients Valeria Sajin, Chisinau, Moldova (University of Lübeck, Germany); Ruxandra Joikits, Timisoara, Romania (IRCCS San Camillo, Italy); Kristina Lauckaite, Kaunas, Lithuania (King’s College Hospital, United Kingdom); Vladimir Han, Kosice, Slovakia (University of Groningen, Netherlands); Sheila Klufio, Accra, Ghana (Newcastle University, United Kingdom). The goal of this grant program is to enable education, training and experience in movement disorders across the region and to foster long term links between medical training and research sites within Europe.
In closing, I would like to thank our Section Officers: Joaquim Ferreira, Anette Schrag, Pille Taba, Murat Emre, Carlo Colosimo and Werner Poewe whose hard work have contributed to our present success.
Olivier Rascol, MD, PhD